Results 31 to 40 of about 1,678,519 (353)

Probiotics for induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews, 2020
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract, in which the pathogenesis is believed to be partly influenced by the gut microbiome. Probiotics can be used to manipulate the microbiome and have therefore been considered as a potential therapy for CD.
Limketkai, Berkeley N, Akobeng, Anthony K, Gordon, Morris, Adepoju, Akinlolu Adedayo   +3 more
openaire   +3 more sources

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial

Annals of the Rheumatic Diseases, 2019
Objectives Cyclophosphamide induction regimens are effective for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), but are associated with infections, malignancies and infertility.
R. Jones, T. Hiemstra, J. Ballarin, D. Blockmans, P. Brogan, A. Bruchfeld, M. Cid, K. Dahlsveen, J. D. de Zoysa, G. Espígol-Frigolé, P. Lanyon, C. Peh, V. Tesar, A. Vaglio, M. Walsh, D. Walsh, G. Walters, L. Harper, D. Jayne   +18 more
semanticscholar   +1 more source

VAD chemotherapy as remission induction for multiple myeloma [PDF]

British Journal of Cancer, 1995
A total of 142 patients with multiple myeloma received VAD as remission induction therapy. Seventy-five were previously untreated and 67 had relapsed (31) or refractory disease (36). Vincristine (total dose 1.6 mg) was infused with doxorubicin 36 mg m-2 by continuous ambulatory pump over 4 days. In addition, oral dexamethasone 40 mg day-1 was given for
H, Anderson, J H, Scarffe, M, Ranson, R, Young, G S, Wieringa, G R, Morgenstern, L, Fitzsimmons, D, Ryder   +7 more
openaire   +2 more sources

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

Haematologica, 2016
Up to 30% of adults with acute myeloid leukemia fail to achieve a complete remission after induction chemotherapy - termed primary refractory acute myeloid leukemia.
Paul Ferguson, Robert K. Hills, Angela Grech, Sophie Betteridge, Lars Kjeldsen, Michael Dennis, Paresh Vyas, Anthony H. Goldstone, Donald Milligan, Richard E. Clark, Nigel H. Russell, Charles Craddock   +11 more
doaj   +1 more source

Successful treatment of idiopathic retroperitoneal fibrosis with combined immunosuppressive therapy [PDF]

Vojnosanitetski Pregled, 2019
Background/Aim. Idiopathic retroperitoneal fibrosis (IRF) is characterized by the fibroinflammatory periaortic tissue that affects the ureters, causing obstructive nephropathy and variable impairment of renal function.
Obrenčević Katarina, Petrović Dejan, Aleksić Predrag, Petrović Marijana, Rančić Nemanja, Jovanović Dragan, Nikolić Bojan, Mijušković Mirjana, Vavić Neven, Ignjatović Ljiljana, Maksić Đoko   +10 more
doaj   +1 more source

Efficacy of adalimumab as second-line therapy in a pediatric cohort of crohn’s disease patients who failed infliximab therapy: The Italian society of pediatric gastroenterology, hepatology, and nutrition experience [PDF]

, 2019
Background: Adalimumab (Ada) treatment is an available option for pediatric Crohn’s disease (CD) and the published experience as rescue therapy is limited.
Accomando S., Aloi M., Alvisi P., Arrigo S., Balzani L., Cucchiara S., De Giacomo C., Gennari M., Guariso G., Knafelz D., Lionetti P., Martelossi S., Miele E., Ravelli A., Romano C., Zuin G.   +15 more
core   +1 more source

End of induction treatment outcomes with a novel cyclophosphamide-based regimen for severe lupus nephritis: Single-center experience from South India

Indian Journal of Rheumatology, 2020
Background: Cyclophosphamide is commonly used along with pulse steroids for induction immunosuppression treatment of severe forms of lupus nephritis (LN).
V Jayaprakash, T Dineshkumar, J Dhanapriya, D Rajasekar, R Sakthirajan, T Balasubramaniyan, Anila A Kurien, N Gopalakrishnan   +7 more
doaj   +1 more source

Steroids in pediatric eosinophilic esophagitis [PDF]

, 2014
Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids.
Contreras, Emily M., Gupta, Sandeep K.
core   +1 more source

Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial.

Journal of Clinical Oncology, 2019
PURPOSE To identify effective and less toxic therapy for children with acute myeloid leukemia, we introduced clofarabine into the first course of remission induction to reduce exposure to daunorubicin and etoposide.
J. Rubnitz, Norman J. Lacayo, H. Inaba, K. Heym, R. Ribeiro, J. Taub, Jennifer L. McNeer, B. Degar, D. Schiff, A. Yeoh, E. Coustan-Smith, Lei Wang, B. Triplett, S. Raimondi, J. Klco, J. Choi, S. Pounds, C. Pui   +17 more
semanticscholar   +1 more source

Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis

The Saudi Journal of Gastroenterology, 2017
Background/Aims: Treatment of refractory ulcerative colitis (UC) is a clinical challenge, and after biological therapy, monitoring clinical and endoscopic responses is fundamental.
Elham A Hassan, Haidi K Ramadan, Ali A Ismael, Khaled F Mohamed, Madiha M El-Attar, Ihab Alhelali   +5 more
doaj   +1 more source